Migraines increase the risk of asthma, and asthma is also associated with an elevated risk of migraine, according to new research.
In the first report of its kind, a recent study compiled Korean Health Insurance Review and Assessment Service data from between 2002 and 2013 to evaluate a bidirectional association between asthma and migraines in Korean adults.
Matching patients and control subjects by age, sex, income, past medical histories, and region of residence, researchers determined asthma and migraines to be reciprocally associated.
“Migraines increase the risk of asthma. Asthma was also associated with an elevated risk of migraine,” researchers said.
In Korea, out of every 1000 adults over the age of 20, between 3.63 and 6.07 suffer from asthma. In addition, approximately 6% of adults in Korea between the ages 19 and 69 suffer from migraines. Worldwide, anywhere from 7% to 18% of the population has asthma and as many as 1.04 billion people experience migraines.
To conduct the study, researchers matched 113,059 patients with asthma to 113,059 control patients, and 36,044 patients with migraines to 114,176 control patients.
In the first cohort, 5.3% of the group with asthma reported experiencing migraines within a follow-up period of around 43 months. This group demonstrated an adjusted hazard ratio (HR) of 1.47 for migraines. In comparison, only 3.4% of the control group reported migraines in the same time period. Although 8% of migraine patients reported having aura in this study, both migraines with and without aura rated higher for presence of asthma than the control group.
In the second cohort, the group suffering from migraines had a 15.4% rate of experiencing asthma after about 42 months, with an adjusted HR of 1.37. In 43 months, the control group reported a 10.6% rate of experiencing asthma.
The researchers were drawn to the question of a reciprocal relationship between the 2 ailments because “The pathophysiology of the hormonal imbalance and environmental triggering factors are common in both migraines and asthma,” they said.
More specifically, atopy, parasympathetic hyperactivity, and elevated neuropeptide secretion are shared pathophysiologic factors of the two conditions.
Additionally, environmental and lifestyle factors such as air pollutants, obesity, and smoking “impact both asthma and migraine,” the researchers said. However, lifestyle factors were not available to include in the study.
Reference
Kim SY, Min C, Oh DJ, Lim JS, Choi HG. Bidirectional association between asthma and migraines in adults: two longitudinal follow-up studies. Sci Rep. 2019;9(18343):1-24. doi:10.1038/s41598-019-54972-8.
Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists
April 20th 2023This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Read More
Update on Migraine Patient Care Challenges During the Pandemic
October 5th 2021Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with a headache specialist about the extra challenges for patients and providers during the pandemic.
Listen
CGRP Inhibitors: A Promising New Class of Drugs for Migraine
November 14th 2018This fall, The American Journal of Managed Care® convened a panel of experts on migraine to discuss calcitonin gene-related peptide (CGRP) inhibitors, an emerging therapy for the condition, which affects 39 million people in the United States.
Listen